Priority and Planning Committees

The Priority and Planning (P&P) Committees are integral to the IG's ability to carry out its mandate. The P&P Committee for each research priority theme gathers input from that research community regarding research priorities. Additional P&P Committees enable IG development in other critical areas, such as international collaborations in human genetics, public engagement, knowledge exchange and new principal investigators.

The P&P Committees foster the development of their research communities; provide a forum for the identification of critical issues and opportunities; and facilitate input from and dialogue with their research communities and the users of their research, including, in some instances, patient groups.

Through the P&P committees, over 100 leading researchers and other committed stakeholders are engaged on a regular basis in informing and advancing the strategic research agenda of the Institute. Each P&P Committee is led or co-led by a distinguished Canadian scientist(s) with experience and strong commitment to advancing research in a specific area. The membership of the P&P Committees is diverse and multidisciplinary, and includes basic science researchers, clinicians, investigators in population and public health, and researchers from the humanities who focus on ethical, legal and social issues.

Priority & Planning Committees Supporting IG Research Priority Themes

From Genes to Genomic Medicine (including Clinical Genetics Research)

Jan Friedman, University of British Columbia (Chair)
Jane Evans, University of Manitoba
Alex MacKenzie, Children’s Hospital of Eastern Ontario Research Institute
Jacques Michaud, Université de Montréal
David Rosenblatt, McGill University
Jacques Simard, Université Laval
Rosanna Weksberg, The Hospital for Sick Children

Genetics and Ethical, Legal and Social Issues

Timothy Caulfield, University of Alberta (Co-Chair)
Daryl Pullman, Memorial University of Newfoundland (Co-Chair)
Susan Cox, University of British Columbia
Jane Evans, University of Manitoba
Jonathan Kimmelman, McGill University
Patricia Kosseim, Genome Canada
Karine Morin, CIHR Ethics Office
Vardit Ravitsky, Université de Montréal
François Rousseau, Université Laval

Health Services for Genetic Diseases
(in partnership with the Institute of Health Services and Policy Research)

Fiona Miller, University of Toronto (Co-Chair)
Jeremy Grimshaw, Ottawa Health Research Institute (Co-Chair)
Denise Avard, Université de Montréal
Renaldo Battista Université de Montréal
Mario Cappelli, Children’s Hospital of Eastern Ontario
June Carroll, Mount Sinai Hospital
François Rousseau, Université Laval
Brenda Wilson, University of Ottawa

Integrating the Physical and Applied Sciences into Health Research

Philip Hieter, University of British Columbia (Co-Chair)
Christopher Yip, University of Toronto (Co-Chair)
Brenda Andrews, University of Toronto
Daniel Coté, Centre de Recherche Université Laval Robert Giffard
Yves De Konick, Université Laval
Charles Haynes, University of British Columbia

Population Genetics, Genetic Epidemiology, and Complex Diseases
(in partnership with the Institute of Population and Public Health)

France Gagnon, University of Toronto (Co-Chair)
Steven Narod, University of Toronto (Co-Chair)
Kristan Aronson, Queen’s University
Shelley Bull, University of Toronto
Jinko Graham, Simon Fraser University
Julian Little, University of Ottawa
Andrew Paterson, The Hospital for Sick Children
Erwin Schurr, McGill University

Priority & Planning Committees Supporting IG Enabling Strategies

Developmental Genetics and Birth Defects

Jacques Drouin, Institut de recherches cliniques de Montréal (Chair)
Paul Lasko, McGill University
Howard Lipshitz, The Hospital for Sick Children
James McGhee, University of Calgary
Jacques Michaud, Université de Montréal
Janet Rossant, The Hospital for Sick Children

New Principal Investigators

Geoff Hicks, University of Manitoba (Chair)
Gregor Andelfinger, CHU Sainte Justine
Frank Beier, University of Western Ontario
Frédéric Charron, Université de Montréal
Anne-Claude Gingras, Samuel Lunenfeld Research Institute
Morrie Manolson, University of Toronto

Voluntary Health Organizations Working Group

Sharon Colle, Foundation Fighting Blindness – Canada (Co-Chair)
Jan Friedman, University of British Columbia (Co-Chair)
Judith Allanson, Children's Hospital of Eastern Ontario
Don Lamont, Huntington Society of Canada
Barbara Snelgrove, Parkinson Society Canada
George Tolomiczenko, Crohn’s &Colitis Foundation of Canada
Durhane Wong-Rieger, Canadian Organization for Rare Disorders